Collard Craig A has filed 41 insider transactions across 2 companies since June 2023.
Most recent transaction: a option exercise of 34789 shares of HERON THERAPEUTICS, INC. /DE/ ($HRTX) on January 31, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 31, 2026 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Collard Craig A | Chief Executive Officer | M | Restricted Stock Units | 34789 | $0.00 | 417,464.0000 | 183,362,522 | 7.69% | 0.02% |
| Jan. 30, 2026 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Collard Craig A | Chief Executive Officer | A | Performance Stock Units | 800336 | $0.00 | 800,336.0000 | 183,362,522 | 9999.99% | 0.44% |
| Jan. 31, 2026 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Collard Craig A | Chief Executive Officer | M | Common Stock | 34789 | $0.00 | 571,710.0000 | 183,362,522 | 6.48% | 0.02% |
| Jan. 30, 2026 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Collard Craig A | Chief Executive Officer | A | Restricted Stock Units | 800337 | $0.00 | 800,337.0000 | 183,362,522 | 9999.99% | 0.44% |
| Jan. 19, 2026 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Collard Craig A | Chief Executive Officer | M | Common Stock | 13797 | $0.00 | 536,921.0000 | 183,362,522 | 2.64% | 0.01% |
| Jan. 19, 2026 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Collard Craig A | Chief Executive Officer | M | Restricted Stock Units | 13797 | $0.00 | 110,375.0000 | 183,362,522 | 11.11% | 0.01% |
| Oct. 31, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Collard Craig A | Chief Executive Officer | M | Restricted Stock Units | 34789 | $0.00 | 452,253.0000 | 183,362,522 | 7.14% | 0.02% |
| Oct. 31, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Collard Craig A | Chief Executive Officer | M | Common Stock | 34789 | $0.00 | 523,124.0000 | 183,362,522 | 7.12% | 0.02% |
| Oct. 19, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Collard Craig A | Chief Executive Officer | M | Common Stock | 13797 | $0.00 | 488,335.0000 | 152,329,588 | 2.91% | 0.01% |
| Oct. 19, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Collard Craig A | Chief Executive Officer | M | Restricted Stock Units | 13797 | $0.00 | 124,172.0000 | 152,329,588 | 10.00% | 0.01% |
| July 31, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Collard Craig A | Chief Executive Officer | M | Restricted Stock Units | 34789 | $0.00 | 487,042.0000 | 152,329,588 | 6.67% | 0.02% |
| July 31, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Collard Craig A | Chief Executive Officer | M | Common Stock | 34789 | $0.00 | 474,538.0000 | 152,329,588 | 7.91% | 0.02% |
| July 19, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Collard Craig A | Chief Executive Officer | M | Common Stock | 13797 | $0.00 | 439,749.0000 | 152,329,588 | 3.24% | 0.01% |
| July 19, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Collard Craig A | Chief Executive Officer | M | Restricted Stock Units | 13797 | $0.00 | 137,969.0000 | 152,329,588 | 9.09% | 0.01% |
| June 24, 2025 | TerrAscend Corp. | $TSNDF | Collard Craig A | Not found | A | Common Shares | 433653 | $0.00 | 1,076,538.0000 | 293,232,131 | 67.45% | 0.15% |
| April 30, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Collard Craig A | Chief Executive Officer | M | Common Stock | 34789 | $0.00 | 425,952.0000 | 152,329,588 | 8.89% | 0.02% |
| April 30, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Collard Craig A | Chief Executive Officer | M | Restricted Stock Units | 34789 | $0.00 | 521,831.0000 | 152,329,588 | 6.25% | 0.02% |
| April 19, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Collard Craig A | Chief Executive Officer | M | Restricted Stock Units | 13796 | $0.00 | 151,766.0000 | 152,329,588 | 8.33% | 0.01% |
| April 19, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Collard Craig A | Chief Executive Officer | M | Common Stock | 13796 | $0.00 | 391,163.0000 | 152,329,588 | 3.66% | 0.01% |
| April 3, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Collard Craig A | Chief Executive Officer | M | Restricted Stock Units | 62500 | $0.00 | 125,000.0000 | 152,329,588 | 33.33% | 0.04% |
| April 3, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Collard Craig A | Chief Executive Officer | M | Common Stock | 62500 | $0.00 | 377,367.0000 | 152,329,588 | 19.85% | 0.04% |
| March 25, 2025 | TerrAscend Corp. | $TSNDF | Collard Craig A | Not found | F | Common Shares | 2258 | $0.46 | 642,885.0000 | 293,232,131 | 0.35% | 0.00% |
| Jan. 31, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Collard Craig A | Chief Executive Officer | A | Employee Stock Option (Right to Buy) | 1113240 | $0.00 | 1,113,240.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Collard Craig A | Chief Executive Officer | A | Restricted Stock Units | 556620 | $0.00 | 556,620.0000 | 0 | 9999.99% | 0.00% |
| Jan. 19, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Collard Craig A | Chief Executive Officer | M | Restricted Stock Units | 13797 | $0.00 | 165,562.0000 | 0 | 7.69% | 0.00% |
| Jan. 19, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Collard Craig A | Chief Executive Officer | M | Common Stock | 13797 | $0.00 | 314,867.0000 | 0 | 4.58% | 0.00% |
| Dec. 31, 2024 | TerrAscend Corp. | $TSNDF | Collard Craig A | Not found | F | Common Shares | 71704 | $0.65 | 645,143.0000 | 288,327,497 | 10.00% | 0.02% |
| Oct. 19, 2024 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Collard Craig A | Chief Executive Officer | M | Common Stock | 13797 | $0.00 | 290,387.0000 | 0 | 4.99% | 0.00% |
| Oct. 19, 2024 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Collard Craig A | Chief Executive Officer | M | Restricted Stock Units | 13797 | $0.00 | 179,359.0000 | 0 | 7.14% | 0.00% |
| July 19, 2024 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Collard Craig A | Chief Executive Officer | M | Common Stock | 13797 | $0.00 | 276,590.0000 | 0 | 5.25% | 0.00% |
| July 19, 2024 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Collard Craig A | Chief Executive Officer | M | Restricted Stock Units | 13797 | $0.00 | 193,156.0000 | 0 | 6.67% | 0.00% |
| June 17, 2024 | TerrAscend Corp. | $TSNDF | Collard Craig A | Not found | D | Share Option (Right to Buy) | 150000 | $0.00 | 0.0000 | 288,327,497 | 100.00% | 0.05% |
| June 17, 2024 | TerrAscend Corp. | $TSNDF | Collard Craig A | Not found | A | Common Shares | 163334 | $0.00 | 716,847.0000 | 288,327,497 | 29.51% | 0.06% |
| June 17, 2024 | TerrAscend Corp. | $TSNDF | Collard Craig A | Not found | A | Share Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 288,327,497 | 9999.99% | 0.05% |
| April 19, 2024 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Collard Craig A | Chief Executive Officer | M | Common Stock | 13797 | $0.00 | 262,793.0000 | 0 | 5.54% | 0.00% |
| Jan. 19, 2024 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Collard Craig A | Chief Executive Officer | M | Restricted Stock Units | 13797 | $0.00 | 206,953.0000 | 0 | 6.25% | 0.00% |
| April 3, 2024 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Collard Craig A | Chief Executive Officer | M | Restricted Stock Units | 62500 | $0.00 | 187,500.0000 | 0 | 25.00% | 0.00% |
| April 3, 2024 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Collard Craig A | Chief Executive Officer | M | Common Stock | 62500 | $0.00 | 248,996.0000 | 0 | 33.51% | 0.00% |
| Jan. 19, 2024 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Collard Craig A | Chief Executive Officer | A | Employee Stock Option (Right to Buy) | 1324502 | $0.00 | 1,324,502.0000 | 0 | 9999.99% | 0.00% |
| Jan. 19, 2024 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Collard Craig A | Chief Executive Officer | A | Restricted Stock Units | 220750 | $0.00 | 220,750.0000 | 0 | 9999.99% | 0.00% |
| June 22, 2023 | TerrAscend Corp. | $TSNDF | Collard Craig A | Director | A | Common Stock | 132647 | $0.00 | 553,513.0000 | 0 | 31.52% | 0.00% |